Purchase Order 75N95024P00497
- Not listed
- This firm-fixed-price purchase order, valued at $24,487.45, was awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization that provides automated genotyping services to support biomedical research. The contract, which has no set-aside designation, is for genotyping testing services to support NIDA's research initiatives. Transnetyx has held numerous federal contracts to provide genomic...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization that provides automated genotyping services. The $18,000.00 contract is for genotyping services to support biomedical research efforts across various federal agencies. Transnetyx has extensive experience supporting NIH institutes, including NIDA, the National Institute of Neurological...
- This is a $20,000 firm-fixed-price purchase order awarded to Transnetyx, Inc. by the National Institute on Drug Abuse, a component of the Department of Health and Human Services. The contract is for Transnetyx's genotyping services to support biomedical research efforts. Transnetyx, a for-profit organization, specializes in DNA extraction, multi-gene analysis, bioinformatics, and automated genotyping services, primarily serving various NIH institutes. The contract is not set-aside. Transnetyx...
- This federal contract award to Transnetyx, Inc., a for-profit organization, is for the provision of automated genotyping services to support biomedical research across various federal agencies. The $24,000 firm fixed-price purchase order is being issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS). Transnetyx has extensive experience supporting research initiatives at the National Institutes of Health (NIH), including the...
- This federal contract award to Transnetyx, Inc. is for PCR for genotyping services, with a ceiling value of $14,000 and a completion date of February 7, 2025. The contract is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS). Transnetyx, Inc., a for-profit organization specializing in automated genotyping, DNA extraction, and bioinformatics services, has extensive experience supporting...
- This is a $15,000 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse, a civilian agency within the Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization headquartered in Cordova, Tennessee. The contract is not set aside and has a completion date of February 19, 2026. Transnetyx is a provider of automated genotyping, DNA extraction, multi-gene analysis, and bioinformatics services primarily for biomedical research purposes,...
- This is a $20,000.00 Firm Fixed Price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization specializing in genetic testing and analysis services. The contract is for genotyping services to support ongoing research experiments involving genetically-modified rats. This award is not set aside and represents part of Transnetyx's broader portfolio of federal contracts,...
- The National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), has awarded a $20,000 firm-fixed-price purchase order contract to Transnetyx, Inc. for genotyping services to support biomedical research efforts. Transnetyx, a for-profit organization, will provide automated DNA extraction, multi-gene analysis, and bioinformatics support for projects related to neurological disorders, environmental health, substance abuse, and age-related diseases....
- This federal contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services. The $15,000 contract is for genotyping services during fiscal year 2019 and has a firm fixed price. Transnetyx has established itself as a critical provider of genetic testing services for various national research institutions,...
- This is a $14,000 firm-fixed-price contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services. The contract is for the genotyping of mice, a critical service supporting NIDA's research programs in areas such as neurological disorders, substance abuse, and age-related conditions. Transnetyx has a strong track record of...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Transnetyx, Inc. The contract, valued at $24,999.00, is for automated genotyping services to support research examining the behavior and cellular mechanisms of learning in addiction. Transnetyx, a for-profit organization, provides a range of genomic services to federal agencies, including DNA extraction, gene analysis, and bioinformatics support. This contract is not set-aside and was competed in the open market. Transnetyx also holds two significant indefinite delivery contracts (IDVs) with the National Institutes of Health, one with the National Institute on Aging for up to $1,465,680 and another with the National Institute of Environmental Health Sciences for up to $7 million, demonstrating the company's critical role in supporting large-scale, ongoing research initiatives within the NIH.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 8/27/24 |